The Malassezia genus in skin and systemic diseases

Clinical Microbiology Reviews

Volumn 25, Issue 1, 2012, Pages 106-141

  Gaitanis, Georgios ^a   Magiatis, Prokopios ^b   Hantschke, Markus ^c   Bassukas, Ioannis D ^a   Velegraki, Aristea ^d  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Dermatopathologie Friedrichshafen   (Germany)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; IMIDAZOLE; INDIRUBIN; INDOLO[3,2 B]CARBAZOLE; ITRACONAZOLE; KETO MALASSEZIN; KETOCONAZOLE; MALASSEZIN; MALASSEZINDOLE A; PITYRIACITRIN; PITYRIALACTONE; PLACEBO; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIMICROBIAL THERAPY; ARTICLE; ATOPIC DERMATITIS; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; INFECTION PREVENTION; MALASSEZIA; MALASSEZIA CAPRAE; MALASSEZIA CUNICULI; MALASSEZIA DERMATIS; MALASSEZIA EQUINA; MALASSEZIA FOLLICULITIS; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA JAPONICA; MALASSEZIA NANA; MALASSEZIA OBTUSA; MALASSEZIA PACHYDERMATIS; MALASSEZIA RESTRICTA; MALASSEZIA SLOOFFIAE; MALASSEZIA SYMPODIALIS; MALASSEZIA YAMATOENSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; ONYCHOMYCOSIS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PSORIASIS; SEBORRHEIC DERMATITIS; SKIN CANCER; SKIN DISEASE; SYSTEMIC DISEASE; TAXONOMY; TINEA VERSICOLOR;

HUMANS; MALASSEZIA; MYCOSES;

ANIMALIA; MALASSEZIA; MALASSEZIA DERMATIS; MALASSEZIA FURFUR; MALASSEZIA GLOBOSA; MALASSEZIA JAPONICA; MALASSEZIA NANA; MALASSEZIA OBTUSA; MALASSEZIA PACHYDERMATIS; MALASSEZIA RESTRICTA; MALASSEZIA SLOOFFIAE; MALASSEZIA SYMPODIALIS; MALASSEZIA YAMATOENSIS;

EID: 84855679770     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00021-11     Document Type: Article

References (355)

1. Adachi J, Mori Y, Matsui S, Matsuda T. 2004. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol. Sci. 80: 161-169.
2. Agerberth B, et al. 2006. Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals. Allergy 61:422-430.
3. Aizawa T, Kano R, Nakamura Y, Watanabe S, Hasegawa A. 2001. The genetic diversity of clinical isolates of Malassezia pachydermatis from dogs and cats. Med. Mycol. 39:329-334.
4. Aizawa T, Kano R, Nakamura Y, Watanabe S, Hasegawa A. 1999. Molecular heterogeneity in clinical isolates of Malassezia pachydermatis from dogs. Vet. Microbiol. 70:67-75.
5. Akaza N, et al. 2009. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med. Mycol. 47:618-624.
6. Akaza N, et al. 2010. Cutaneous Malassezia microbiota in atopic dermatitis patients differ by gender and body part. Dermatology 221: 253-260.
7. Alpert G, Bell LM, Campos JM. 1987. Malassezia furfur fungemia in infancy. Clin. Pediatr. (Phila.) 26:528-531.
8. Alves EV, Martins JE, Ribeiro EB, Sotto MN. 2000. Pityrosporum folliculitis: renal transplantation case report. J. Dermatol. 27:49-51.
9. Amaya M, et al. 2007. Molecular analysis of Malassezia microflora in the lesional skin of psoriasis patients. J. Dermatol. 34:619-624.
10. Andersson A, et al. 2004. Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase. Eur. J. Biochem. 271:1885-1894.
11. Aoba S, Komiyama A, Hasegawa O. 1993. Fungal meningitis caused by a Malassezia species masquerading as painful ophthalmoplegia. Rinsho Shinkeigaku 33:462-464.
12. Archer-Dubon C, et al. 1999. An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection. Int. J. Dermatol. 38:453-456.
13. Arnow PM, Kushner R. 1991. Malassezia furfur catheter infection cured with antibiotic lock therapy. Am. J. Med. 90:128-130.
14. Ashbee HR, Evans EG. 2002. Immunology of diseases associated with Malassezia species. Clin. Microbiol. Rev. 15:21-57.
15. Atherton DJ, Gennery AR, Cant AJ. 2004. The neonate, p 1422-1429. In Burns T, Breathnach S, Cox N, Griffiths C (ed), Rooks textbook of dermatology, 7th ed. Blackwell Publishing, Oxford, United Kingdom.
16. Ayers K, Sweeney SM, Wiss K. 2005. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch. Pediatr. Adolesc. Med. 159:64-67.
17. Azimi PH, et al. 1988. Malassezia furfur: a cause of occlusion of percutaneous central venous catheters in infants in the intensive care nursery. Pediatr. Infect. Dis. J. 7:100-103.
18. Bäck O, Faergemann J, Hörnqvist R. 1985. Pityrosporum folliculitis: a common disease of the young and middle-aged. J. Am. Acad. Dermatol. 12:56-61.
19. Baillon H. 1889. Traité de botanique médicale cryptogamique, paris, 4th ed. Octave Doin, Paris, France.
20. Balaji H, et al. 2011. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J. Allergy Clin. Immunol. 128:92-99.
21. Bamford JT. 1983. Treatment of tinea versicolor with sulfur-salicylic shampoo. J. Am. Acad. Dermatol. 8:211-213.
22. Bankoti J, Rase B, Simones T, Shepherd DM. 2010. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol. Appl. Pharmacol. 246:18-28.
23. Barber GR, Brown AE, Kiehn TE, Edwards FF, Armstrong D. 1993. Catheter-related Malassezia furfur fungemia in immunocompromised patients. Am. J. Med. 95:365-370.
24. Barchmann T, Hort W, Krämer HJ, Mayser P. 2011. Glycine as a regulator of tryptophan-dependent pigment synthesis in Malassezia furfur. Mycoses 54:17-22.
25. Barfatani M, Munn RJ, Schjeide OA. 1964. An ultrastructure study of Pityrosporum orbiculare. J. Invest. Dermatol. 43:231-233.
26. Baroni A, et al. 2006. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch. Dermatol. Res. 297:280-288.
27. Baroni A, et al. 2004. Possible role of Malassezia furfur in psoriasis: modulation of TGF-beta1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J. Cutan. Pathol. 31:35-42.
28. Baroni A, et al. 2001. Malassezia furfur invasiveness in a keratinocyte cell line (HaCat): effects on cytoskeleton and on adhesion molecule and cytokine expression. Arch. Dermatol. Res. 293:414-419.
29. Bhargava P, Longhi LP. 2007. Images in clinical medicine. Peripheral smear with Malassezia furfur. N. Engl. J. Med. 356:e25.
30. Bieber T. 2008. Atopic dermatitis. N. Engl. J. Med. 358:1483-1494.
31. Binder RL, Jonelis FJ. 1983. Seborrheic dermatitis in neurolepticinduced Parkinsonism. Arch. Dermatol. 119:473-475.
32. Bizzozero J. 1884. Über die Mykrophyten der normalen Oberhaut des Menschen. Virchows Arch. Pathol. Anat. Physiol. 98:441-459.
33. Bond R, Cabañes GJJ. 2010. Malassezia yeasts in animal disease, p 271-300. In Boekhout T, Gue ́ho E, Mayser P, Velegraki A (ed), Malassezia and the skin. Science and clinical practice. Springer, Berlin, Germany.
34. Brooks R, Brown L. 1987. Systemic infection with Malassezia furfur in an adult receiving long-term hyperalimentation therapy. J. Infect. Dis. 156:410-411.
35. Brunke S, Hube B. 2006. MfLIP1, a gene encoding an extracellular lipase of the lipid-dependent fungus Malassezia furfur. Microbiology 152: 547-554.
36. Bulmer GS, Pu XM, Yi LX. 2008. Malassezia folliculitis in China. Mycopathologia 165:411-412.
37. Burton JL, Pye RJ. 1983. Seborrhoea is not a feature of seborrhoeic dermatitis. Br. Med. J. (Clin. Res. Ed.) 286:1169-1170.
38. Cabanes FJ, Hernandez JJ, Castella G. 2005. Molecular analysis of Malassezia sympodialis-related strains from domestic animals. J. Clin. Microbiol. 43:277-283.
39. Cabanes FJ, Theelen B, Castella G, Boekhout T. 2007. Two new lipiddependent Malassezia species from domestic animals. FEMS Yeast Res. 7:1064-1076.
40. Cabanes FJ, Vega S, Castella G. 2011. Malassezia cuniculi sp. nov., a novel yeast species isolated from rabbit skin. Med. Mycol. 49:40-48.
41. Cafarchia C, Dell'Aquila ME, Capelli G, Minoia P, Otranto D. 2007. Role of beta-endorphin on phospholipase production in Malassezia pachydermatis in dogs: new insights into the pathogenesis of this yeast. Med. Mycol. 45:11-15.
42. Cafarchia C, et al. 2010. Expression of the micro-opioid receptor on Malassezia pachydermatis and its effect in modulating phospholipase production. Med. Mycol. 48:73-78.
43. Cafarchia C, et al. 2008. Genetic variants of Malassezia pachydermatis from canine skin: body distribution and phospholipase activity. FEMS Yeast Res. 8:451-459.
44. Cafarchia C, Otranto D. 2004. Association between phospholipase production by Malassezia pachydermatis and skin lesions. J. Clin. Microbiol. 42:4868-4869.
45. Cafarchia C, et al. 2007. Multilocus mutation scanning for the analysis of genetic variation within Malassezia (Basidiomycota: Malasseziales). Electrophoresis 28:1176-1180.
46. Cafarchia C, et al. 2007. Molecular characterization of Malassezia isolates from dogs using three distinct genetic markers in nuclear DNA. Mol. Cell. Probes 21:229-238.
47. Canteros CE, et al. 2007. Concordance between phenotypical features and PCR-REA for the identification of Malassezia spp. Rev. Iberoam. Micol. 24:278-282.
48. Casagrande BF, et al. 2006. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J. Invest. Dermatol. 126:2414-2421.
49. Castella G, Hernandez JJ, Cabanes FJ. 2005. Genetic typing of Malassezia pachydermatis from different domestic animals. Vet. Microbiol. 108: 291-296.
50. Castellani A, Chalmers AJ. 1913. Manual of tropical medicine, 2nd ed. Baillière, Tindal, and Cox, London, United Kingdom.
51. Chai FC, Auret K, Christiansen K, Yuen PW, Gardam D. 2000. Malignant otitis externa caused by Malassezia sympodialis. Head Neck 22:87-89.
52. Chang HJ, et al. 1998. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. N. Engl. J. Med. 338:706-711.
53. Chaudhary R, Singh S, Banerjee T, Tilak R. 2010. Prevalence of different Malassezia species in pityriasis versicolor in central India. Indian J. Dermatol. Venereol. Leprol. 76:159-164.
54. Chen YH, et al. 1995. Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells. J. Biol. Chem. 270:22548-22555.
55. Chetty GN, Kamalam A, Thambiah AS. 1979. Pityriasis versicolor-a study of 200 cases in a tropical skin clinic. Mykosen 22:234-236.
56. Cholongitas E, Pipili C, Ioannidou D. 2009. Malassezia folliculitis presented as acneiform eruption after cetuximab administration. J. Drugs Dermatol. 8:274-275.
57. Chowdhary A, Randhawa HS, Sharma S, Brandt ME, Kumar S. 2005. Malassezia furfur in a case of onychomycosis: colonizer or etiologic agent? Med. Mycol. 43:87-90.
58. Chryssanthou E, Broberger U, Petrini B. 2001. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr. 90: 323-327.
59. Chu CM, Lai RW. 2002. Malassezia furfur fungaemia in a ventilatordependent patient without known risk factors. Hong Kong Med. J. 8:212-214.
60. Cork MJ, et al. 2009. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129:1892-1908.
61. Cotterill JA, Cunliffe WJ, Williamson B, Bulusu L. 1972. Age and sex variation in skin surface lipid composition and sebum excretion rate. Br. J. Dermatol. 87:333-340.
62. Coutinho SD, Paula CR. 2000. Proteinase, phospholipase, hyaluronidase and chondroitin-sulphatase production by Malassezia pachydermatis. Med. Mycol. 38:73-76.
63. Crespo Erchiga V, Ojeda Martos A, Vera Casano A, Crespo Erchiga A, Sanchez Fajardo F. 2000. Malassezia globosa as the causative agent of pityriasis versicolor. Br. J. Dermatol. 143:799-803.
64. Crespo Erchiga V, Ojeda Martos AA, Vera Casano A, Crespo Erchiga A, Sanchez Fajardo F. 1999. Isolation and identification of Malassezia spp. in pytiriasis versicolor, seborrheic dermatitis and healthy skin. Rev. Iberoam. Micol. 16:S16-S21.
65. Crespo Erchiga V, Hay RJ. 2010. Pityriasis versicolor and other Malassezia skin diseases, p 175-199. In Boekhout T, Gue ́ho E, Mayser P, Velegraki A (ed), Malassezia and the skin. Science and clinical practice. Springer, Berlin, Germany.
66. Crowson AN, Magro CM. 2003. Atrophying tinea versicolor: a clinical and histological study of 12 patients. Int. J. Dermatol. 42:928-932.
67. Crozier WJ, Wise KA. 1993. Onychomycosis due to Pityrosporum. Australas. J. Dermatol. 34:109-112.
68. Cuetara MS, Aguilar A, Martin L, Aspiroz C, del Palacio A. 2006. Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis. Br. J. Dermatol. 155:477-479.
69. Cunningham AC, Leeming JP, Ingham E, Gowland G. 1990. Differentiation of three serovars of Malassezia furfur. J. Appl. Bacteriol. 68: 439-446.
70. Curvale-Fauchet N, Botterel F, Legrand P, Guillot J, Bretagne S. 2004. Frequency of intravascular catheter colonization by Malassezia spp. in adult patients. Mycoses 47:491-494.
71. Dahms K, Krämer H-J, Thoma W, Mayser P. 2002. Tyrosinaseinhibition durch Tryptophanmetabolite von Malassezia furfur in humaner Epidermis. Mycoses 45:230.
72. Dankner WM, Spector SA, Fierer J, Davis CE. 1987. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev. Infect. Dis. 9:743-753.
73. Danz H, Stoyanova S, Wippich P, Brattstrom A, Hamburger M. 2001. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria. Planta Med. 67:411-416.
74. Dawson TL, Jr. 2007. Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J. Invest. Dermatol. Symp. Proc. 12:15-19.
75. DeAngelis YM, et al. 2005. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J. Invest. Dermatol. Symp. Proc. 10:295-297.
76. DeAngelis YM, et al. 2007. Isolation and expression of a Malassezia globosa lipase gene, LIP1. J. Invest. Dermatol. 127:2138-2146.
77. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. 2009. Atopic dermatitis: a disease caused by innate immune defects? J. Invest. Dermatol. 129:14-30.
78. Dehghan M, Akbari N, Alborzi N, Sadani S, Keshtkar AA. 2010. Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: a double-blind randomized controlled trial. J. Dermatol. 37:699-702.
79. De Jong MA, et al. 2010. C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol. Immunol. 47:1216-1225.
80. De Luca C, Picardo M, Breathnach A, Passi S. 1996. Lipoperoxidase activity of Pityrosporum: characterisation of by-products and possible role in pityriasis versicolor. Exp. Dermatol. 5:49-56.
81. De Waard PW, et al. 2008. A human intervention study with foods containing natural Ah-receptor agonists does not significantly show AhR-mediated effects as measured in blood cells and urine. Chem. Biol. Interact. 176:19-29.
82. Diaz MR, et al. 2006. Microcoding and flow cytometry as a highthroughput fungal identification system for Malassezia species. J. Med. Microbiol. 55:1197-1209.
83. Difonzo EM, Faggi E. 2008. Skin diseases associated with Malassezia species in humans. Clinical features and diagnostic criteria. Parassitologia 50:69-71.
84. Di Silverio A, Zeccara C, Serra F, Ubezio S, Mosca M. 1995. Pityriasis versicolor in a newborn. Mycoses 38:227-228.
85. Di Silverio A, Mosca M, Brandozzi G, Gatti M. 1989. Pityriasis versicolor in the aged: a clinical investigation and epidemiological survey in 190 elderly hospitalized patients. Mycopathologia 105:187-190.
86. Donnarumma G, et al. 2004. Malassezia furfur induces the expression of beta-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch. Dermatol. Res. 295:474-481.
87. Dorn M, Roehnert K. 1977. Dimorphism of Pityrosporum orbiculare in a defined culture medium. J. Invest. Dermatol. 69:244-248.
88. Duarte ER, Hamdan JS. 2010. RAPD differentiation of Malassezia spp. from cattle, dogs and humans. Mycoses 53:48-56.
89. Dutta S, Bajaj AK, Basu S, Dikshit A. 2002. Pityriasis versicolor: socioeconomic and clinico-mycologic study in India. Int. J. Dermatol. 41:823-824.
90. Ebert B, Seidel A, Lampen A. 2005. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26: 1754-1763.
91. Eichstedt E. 1846. Pilzbildung in der Pityriasis versicolor. Froriep. Neue Notiz. Natur. Heilk. 39:270.
92. Elewski B. 1990. Does pityrosporum ovale have a role in psoriasis? Arch. Dermatol. 126:1111-1112.
93. el-Hefnawi H, el-Gothamy Z, Refai M. 1971. Studies on pityriasis versicolor in Egypt. I. Incidence. Mykosen 14:225-231.
94. Epstein EH. 2008. Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer 8:743-754.
95. Ertam I, Aytimur D, Alper S. 2007. Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient. Indian J. Dermatol. Venereol. Leprol. 73:425-426.
96. Esser C, Rannug A, Stockinger B. 2009. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30:447-454.
97. Faergemann J. 1992. Pityrosporum infections, p 69-83. In Elewski BE (ed), Cutaneous fungal infections. Igaku-Shoin, New York, NY.
98. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. 2001. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br. J. Dermatol. 144:549-556.
99. Faergemann J, Johansson S, Bäck O, Scheynius A. 1986. An immunologic and cultural study of Pityrosporum folliculitis. J. Am. Acad. Dermatol. 14:429-433.
100. Faergemann J, et al. 2009. A double-blind, randomized, placebocontrolled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor. J. Am. Acad. Dermatol. 61:971-976.
101. Farr PM, Krause LB, Marks JM, Shuster S. 1985. Response of scalp psoriasis to oral ketoconazole. Lancet ii:921-922.
102. Ferreira J, et al. 2007. Skin cancers and precancerous lesions in Parkinson's disease patients. Mov. Disord. 22:1471-1475.
103. Fine RN, et al. 1983. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Pediatrics 71:806-809.
104. Fredriksson T, Faergemann J. 1983. Double-blind comparison of a zinc pyrithione shampoo and its shampoo base in the treatment of tinea versicolor. Cutis 31:436-437.
105. Fritsche E, et al. 2007. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. U. S. A. 104:8851-8856.
106. Gaitanis G, Bassukas ID, Velegraki A. 2009. The range of molecular methods for typing Malassezia. Curr. Opin. Infect. Dis. 22:119-225.
107. Gaitanis G, Chasapi V, Velegraki A. 2005. Novel application of the Masson-Fontana stain for demonstrating Malassezia species melaninlike pigment production in vitro and in clinical specimens. J. Clin. Microbiol. 43:4147-4151.
108. Gaitanis G, et al. 2008. AhR ligands, malassezin, and indolo[3,2- b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J. Invest. Dermatol. 128:1620-1625.
109. Gaitanis G, Menounos P, Katsambas A, Velegraki A. 2003. Detection and mutation screening of Malassezia sympodialis sequences coding for the Mal s 1 allergen implicated in atopic dermatitis. J. Invest. Dermatol. 121:1559-1560.
110. Gaitanis G, Mayser P, Scheynius A, Crameri R. 2010. Malassezia yeasts in seborrheic and atopic eczemas, p 201-228. In Boekhout T, Gue ́ho E, Mayser P, Velegraki A (ed), Malassezia and the skin. Science and clinical practice. Springer, Berlin, Germany.
111. Gaitanis G, Robert V, Velegraki A. 2006. Verifiable single nucleotide polymorphisms of the internal transcribed spacer 2 region for the identification of 11 Malassezia species. J. Dermatol. Sci. 43:214-217.
112. Gaitanis G, et al. 2006. Distribution of Malassezia species in pityriasis versicolor and seborrhoeic dermatitis in Greece. Typing of the major pityriasis versicolor isolate M. globosa. Br. J. Dermatol. 154:854-859.
113. Gaitanis G, et al. 2009. Malassezia furfur fingerprints as possible markers for human phylogeography. ISME J. 3:498-502.
114. Gaitanis G, et al. 2002. Identification of Malassezia species from patient skin scales by PCR-RFLP. Clin. Microbiol. Infect. 8:162-173.
115. Gaitanis G, Velegraki A, Magiatis P, Pappas P, Bassukas ID. 2011. Could Malassezia yeasts be implicated in skin carcinogenesis through the production of aryl-hydrocarbon receptor ligands? Med. Hypotheses 77: 47-51.
116. Gambichler T, et al. 2007. Quantification of ultraviolet protective effects of pityriacitrin in humans. Arch. Dermatol. Res. 299:517-520.
117. Gandra RF, et al. 2006. Genotyping by RAPD-PCR analyses of Malassezia furfur strains from pityriasis versicolor and seborrhoeic dermatitis patients. Mycopathologia 162:273-280.
118. Garcia CR, Johnston BL, Corvi G, Walker LJ, George WL. 1987. Intravenous catheter-associated Malassezia furfur fungemia. Am. J. Med. 83:790-792.
119. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T, Dawson TL Jr. 2002. Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J. Clin. Microbiol. 40:3350-3357.
120. Giakoumaki D, et al. 2008. Identification of indirubin as a metabolite of Malassezia furfur strains isolated from diseased skin. Planta Med. 74: 1081.
121. Gidding H, Hawes L, Dwyer B. 1989. The isolation of Malassezia furfur from an episode of peritonitis. Med. J. Aust. 151:603.
122. Giusiano G, de los Angeles Sosa M, Rojas F, Vanacore ST, Mangiaterra M. 2010. Prevalence of Malassezia species in pityriasis versicolor lesions in northeast Argentina. Rev. Iberoam. Micol. 27:71-74.
123. Glaser AG, et al. 2006. Analysis of the cross-reactivity and of the 1.5 A crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem. J. 396:41-49.
124. Glaser CA, Atwater SK. 1995. Febrile infant with a percutaneous vascular catheter. Pediatr. Infect. Dis. J. 14:163, 165-166.
125. Gonzalez A, et al. 2009. Physiological and molecular characterization of atypical isolates of Malassezia furfur. J. Clin. Microbiol. 47:48-53.
126. Goodfield MJ, Saihan EM, Crowley J. 1987. Experimental folliculitis with Pityrosporum orbiculare: the influence of host response. Acta Derm. Venereol. 67:445-447.
127. Gordon MA. 1951. The lipophilic mycoflora of the skin. 1. In Vitro culture of Pityrosporum orbiculare n. sp. Mycologia 43:524-535.
128. Graham LM, Brown GD. 2009. The dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine 48:148-155.
129. Guého E, Midgley G, Guillot J. 1996. The genus Malassezia with description of four new species. Antonie Van Leeuwenhoek 69:337-355.
130. Guillot J, Deville M, Berthelemy M, Provost F, Guého E. 2000. A singlePCR-restriction endonuclease analysis for rapid identification of Malassezia species. Lett. Appl. Microbiol. 31:400-403.
131. Guillot J, Guého E. 1995. The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie Van Leeuwenhoek 67:297-314.
132. Guillot J, Lesourd EGM, Midgley G, Chévrier G, Dupont B. 1996. Identification of Malassezia species: a practical approach. J. Mycol. Med. 6:103-110.
133. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. 2004. Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol. 51: 785-798.
134. Gupta AK, Boekhout T, Theelen B, Summerbell R, Batra R. 2004. Identification and typing of Malassezia species by amplified fragment length polymorphism and sequence analyses of the internal transcribed spacer and large-subunit regions of ribosomal DNA. J. Clin. Microbiol. 42:4253-4260.
135. Gupta AK, Kohli Y. 2004. Prevalence of Malassezia species on various body sites in clinically healthy subjects representing different age groups. Med. Mycol. 42:35-42.
136. Gupta AK, Kohli Y, Faergemann J, Summerbell RC. 2001. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med. Mycol. 39:199-206.
137. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC. 2000. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br. J. Dermatol. 142:758-765.
138. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. 2001. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med. Mycol. 39:243-251.
139. Gustafsson BA. 1955. Otitis externa in the dog. A bacteriological and experimental study. Ph.D. thesis. Royal Veterinary College, Stockholm, Sweden.
140. Hafez M, el-Shamy S. 1985. Genetic susceptibility in pityriasis versicolor. Dermatologica 171:86-88.
141. Han A, et al. 2009. Evoked scale sign of tinea versicolor. Arch. Dermatol. 145:1078.
142. Hassall E, Ulich T, Ament ME. 1983. Pulmonary embolus and Malassezia pulmonary infection related to urokinase therapy. J. Pediatr. 102: 722-725.
143. Hazen KC. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
144. He SM, et al. 2008. The genetic epidemiology of tinea versicolor in China. Mycoses 51:55-62.
145. Heckmann M, Zogelmeier F, Konz B. 2002. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure. Arch. Dermatol. 138:1494-1497.
146. Hedayati MT, et al. 2010. Identification of Malassezia species isolated from Iranian seborrhoeic dermatitis patients. Eur. Rev. Med. Pharmacol. Sci. 14:63-68.
147. Hellgren L, Vincent J. 1983. The incidence of tinea versicolor in central Sweden. J. Med. Microbiol. 16:501-502.
148. Hier SW, Cornbleet T, Bergeim O. 1946. The amino acids of human sweat. J. Biol. Chem. 166:327-333.
149. Hill MK, Goodfield MJ, Rodgers FG, Crowley JL, Saihan EM. 1990. Skin surface electron microscopy in Pityrosporum folliculitis. The role of follicular occlusion in disease and the response to oral ketoconazole. Arch. Dermatol. 126:1071-1074.
150. Hirai A, et al. 2004. Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int. J. Syst. Evol. Microbiol. 54: 623-627.
151. Hort W, Mayser P. 2011. Malassezia virulence determinants. Curr. Opin. Infect. Dis. 24:100-105.
152. Hruszkewycz V, et al. 1991. Complications associated with central venous catheters inserted in critically ill neonates. Infect. Control Hosp. Epidemiol. 12:544-548.
153. Hu SW, Bigby M. 2010. Pityriasis versicolor: a systematic review of interventions. Arch. Dermatol. 146:1132-1140.
154. Hutchin ME, et al. 2005. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 19:214-223.
155. Ikuta T, Namiki T, Fujii-Kuriyama Y, Kawajiri K. 2009. AhR protein trafficking and function in the skin. Biochem. Pharmacol. 77:588-596.
156. Ingordo V, Naldi L, Colecchia B, Licci N. 2003. Prevalence of pityriasis versicolor in young Italian sailors. Br. J. Dermatol. 149:1270-1272.
157. Irlinger B, Bartsch A, Krämer HJ, Mayser P, Steglich W. 2005. New tryptophan metabolites from cultures of the lipophilic yeast Malassezia furfur. Helv. Chim. Acta 88:1472-1485.
158. Irlinger B, Krämer HJ, Mayser P, Steglich W. 2004. Pityriarubins, biologically active bis(indolyl)spirans from cultures of the lipophilic yeast Malassezia furfur. Angew. Chem. Int. Ed. Engl. 43:1098-1100.
159. Ishibashi Y, Kato H, Asahi Y, Sugita T, Nishikawa A. 2009. Identification of the major allergen of Malassezia globosa relevant for atopic dermatitis. J. Dermatol. Sci. 55:185-192.
160. Ishibashi Y, Sugawara K, Sugita T, Nishikawa A. 2011. Secretion of thymic stromal lymphopoietin from human keratinocytes in response to Malassezia yeasts. J. Dermatol. Sci. 62:134-138.
161. Ishibashi Y, Sugita T, Nishikawa A. 2006. Cytokine secretion profile of human keratinocytes exposed to Malassezia yeasts. FEMS Immunol. Med. Microbiol. 48:400-409.
162. Ishihara T, et al. 2000. Tryptanthrin inhibits nitric oxide and prostaglandin E(2) synthesis by murine macrophages. Eur. J. Pharmacol. 407: 197-204.
163. Jacinto-Jamora S, Tamesis J, Katigbak ML. 1991. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management. J. Am. Acad. Dermatol. 24:693-696.
164. Jang SJ, et al. 2009. The investigation on the distribution of Malassezia yeasts on the normal Korean skin by 26S rDNA PCR-RFLP. Ann. Dermatol. 21:18-26.
165. Jing W, Ismail R. 1999. Mucocutaneous manifestations of HIV infection: a retrospective analysis of 145 cases in a Chinese population in Malaysia. Int. J. Dermatol. 38:457-463.
166. Johansson SG, et al. 2004. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 113:832-836.
167. Johnson AS, Bailey E, Wright PA, Solomon L. 1996. Malassezia furfur: a possible cause of culture-negative CAPD peritonitis. Perit. Dial. Int. 16:187-188.
168. Jowkar F, Jamshidzadeh A, Pakniyat S, Namazi MR. 2010. Efficacy of nitric oxide-liberating cream on pityriasis versicolor. J. Dermatolog. Treat. 21:93-96.
169. Ju Q, et al. 2011. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp. Dermatol. 20:320-325.
170. Kaneko T, Murotani M, Ohkusu K, Sugita T, Makimura K. Genetic and biological features of catheter-associated Malassezia furfur. Med. Mycol., in press.
171. Kaneko T, et al. 2010. Human external ear canal as the specific reservoir of Malassezia slooffiae. Med. Mycol. 48:824-827.
172. Kaporis HG, et al. 2007. Human basal cell carcinoma is associated with Foxp3_T cells in a Th2 dominant microenvironment. J. Invest. Dermatol. 127:2391-2398.
173. Karakaş M, Turaç-Biçer A, Ilkit M, Durdu M, Seydaoǧlu G. 2009. Epidemiology of pityriasis versicolor in Adana, Turkey. J. Dermatol. 36: 377-382.
174. Kerkvliet NI. 2009. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 77:746-760.
175. Kessler AT, Kourtis AP, Simon N. 2002. Peripheral thromboembolism associated with Malassezia furfur sepsis. Pediatr. Infect. Dis. J. 21: 356-357.
176. Kikuchi K, et al. 2001. A case of central venous catheter-related infection with Malassezia sympodialis. Nippon Ishinkin Gakkai Zasshi 42: 220-222. (In Japanese.)
177. Kim D, Lim YR, Ohk SO, Kim BJ, Chun YJ. 2011. Functional expression and characterization of CYP51 from dandruff-causing Malassezia globosa. FEMS Yeast Res. 11:80-87.
178. Kim J, et al. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155:2240-2247.
179. Kim YJ, Kim YC. 2007. Successful treatment of pityriasis versicolor with 5-aminolevulinic acid photodynamic therapy. Arch. Dermatol. 143: 1218-1220.
180. Kindo AJ, Sophia SK, Kalyani J, Anandan S. 2004. Identification of Malassezia species. Indian J. Med. Microbiol. 22:179-181.
181. Kligman AM. 1979. Perspectives and problems in cutaneous gerontology. J. Invest. Dermatol. 73:39-46.
182. Knockaert M, et al. 2004. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 23:4400-4412.
183. Krämer HJ, et al. 2005. Pityriarubins, novel highly selective inhibitors of respiratory burst from cultures of the yeast Malassezia furfur: comparison with the bisindolylmaleimide arcyriarubin A. Chembiochem 6:2290-2297.
184. Krämer HJ, et al. 2005. Malassezin, a novel agonist of the aryl hydrocarbon receptor from the yeast Malassezia furfur, induces apoptosis in primary human melanocytes. Chembiochem 6:860-865.
185. Krisanty RI, Bramono K, Made Wisnu I. 2009. Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics. Mycoses 52:257-262.
186. Kroumpouzos G. 2005. Pityrosporum folliculitis during pregnancy is not pruritic folliculitis of pregnancy. J. Am. Acad. Dermatol. 53:1098-1099.
187. Kumar CP, Kumar SS, Menon T. 2006. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 161:213-218.
188. Kwon C-S, Grose RK, Riby J, Chen Y-H, Bjeldanes LF. 1994. In vivo production and enzyme-inducing activity of indolo[3,2-b]carbazole. J. Agric. Food Chem. 42:2536-2540.
189. Kyriakis KP, Palamaras STI, Pagana G, Michailides C, Emmanuelides S. 2006. Pityriasis versicolor prevalence by age and gender. Mycoses 49: 517-518.
190. Larangeira de Almeida H, Jr, Mayser P. 2006. Absence of sunburn in lesions of pityriasis versicolor alba. Mycoses 49:516.
191. Larocco M, Dorenbaum A, Robinson A, Pickering LK. 1988. Recovery of Malassezia pachydermatis from eight infants in a neonatal intensive care nursery: clinical and laboratory features. Pediatr. Infect. Dis. J. 7:398-401.
192. Lautenbach E, Nachamkin I, Schuster MG. 1998. Malassezia pachydermatis infections. N. Engl. J. Med. 339:270-271.
193. Lee WJ, et al. 2011. Disruption of barrier function in dermatophytosis and pityriasis versicolor. J. Dermatol. 38:1049-1053.
194. Lee YW, et al. 2008. Isolation of 19 strains of Malassezia dermatis from healthy human skin in Korea. J. Dermatol. 35:772-777.
195. Lee YW, Yim SM, Lim SH, Choe YB, Ahn KJ. 2006. Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea. Mycoses 49:405-410.
196. Leeming JP, Holland KT, Bojar RA. 1986. The in vitro antimicrobial effect of azelaic acid. Br. J. Dermatol. 115:551-556.
197. Leeming JP, Notman FH. 1987. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J. Clin. Microbiol. 25:2017-2019.
198. Levy MS, Polsky D, Davidson A, Strober BE. 2008. Tinea versicolor associated with etanercept therapy. J. Am. Acad. Dermatol. 58:S99-S100.
199. Limacher A, et al. 2007. Cross-reactivity and 1.4-A crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new panallergen family. J. Immunol. 178:389-396.
200. Lin YK, et al. 2008. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch. Dermatol. 144:1457-1464.
201. Liu H, Wormke M, Safe SH, Bjeldanes LF. 1994. Indolo[3,2- b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J. Natl. Cancer Inst. 86:1758-1765.
202. Lober CW, Belew PW, Rosenberg EW, Bale G. 1982. Patch tests with killed sonicated microflora in patients with psoriasis. Arch. Dermatol. 118:322-325.
203. Long JG, Keyserling HL. 1985. Catheter-related infection in infants due to an unusual lipophilic yeast-Malassezia furfur. Pediatrics 76:896-900.
204. Luecke S, et al. 2010. The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis. Pigment Cell Melanoma Res. 23: 828-833.
205. Machado ML, et al. 2010. Genetic variability and phospholipase production of Malassezia pachydermatis isolated from dogs with diverse grades of skin lesions. Med. Mycol. 48:889-892.
206. Machowinski A, Krämer HJ, Hort W, Mayser P. 2006. Pityriacitrin-a potent UV filter produced by Malassezia furfur and its effect on human skin microflora. Mycoses 49:388-392.
207. Makimura K, et al. 2000. Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J. Med. Microbiol. 49:29-35.
208. Malassez L. 1874. Note sur le champignon du pityriasis simple. Arch. Physiol. 1:451-459.
209. Marcon MJ, Durrell DE, Powell DA, Buesching WJ. 1987. In vitro activity of systemic antifungal agents against Malassezia furfur. Antimicrob. Agents Chemother. 31:951-953.
210. Marcus LC, Marcus E. 1998. Nosocomial zoonoses. N. Engl. J. Med. 338:757-759.
211. Massone G, Cavalchini A, Clapasson A, Nunzi E. 2010. Hypopigmented macules: leprosy, atopy or pityriasis versicolor. G. Ital. Dermatol. Venereol. 145:779-782.
212. Masure O, et al. 1991. Malassezia furfur septicaemia in a child with leukaemia. J. Infect. 23:335-336.
213. Mayser P, Gaitanis G. 2010. Physiology and biochemistry, p 121-138. In Boekhout T, Guého E, Mayser P, Velegraki A (ed), Malassezia and the skin. Science and clinical practice. Springer, Berlin, Germany.
214. Mayser P, Rieche I. 2009. Rapid reversal of hyperpigmentation in pityriasis versicolor upon short-term topical cycloserine application. Mycoses 52:541-543.
215. Mayser P, Schafer U, Krämer HJ, Irlinger B, Steglich W. 2002. Pityriacitrin- an ultraviolet-absorbing indole alkaloid from the yeast Malassezia furfur. Arch. Dermatol. Res. 294:131-134.
216. Mayser P, et al. 2003. Pityrialactone-a new fluorochrome from the tryptophan metabolism of Malassezia furfur. Antonie Van Leeuwenhoek 84:185-191.
217. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. 1975. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrheic dermatitis. J. Invest. Dermatol. 64:401-405.
218. Merisalu A, et al. 2007. The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility. Fertil. Steril. 88:854-859.
219. Mickelsen PA, Viano-Paulson MC, Stevens DA, Diaz PS. 1988. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J. Infect. Dis. 157:1163-1168.
220. Middleton C, Lowenthal RM. 1987. Malassezia furfur fungemia as a treatable cause of obscure fever in a leukemia patient receiving parenteral nutrition. Aust. N. Z. J. Med. 17:603-604.
221. Midgley G. 1989. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologia 106:143-153.
222. Midreuil F, et al. 1999. Genetic diversity in the yeast species Malassezia pachydermatis analysed by multilocus enzyme electrophoresis. Int. J. Syst. Bacteriol. 49:1287-1294.
223. Mirhendi H, et al. 2005. A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. J. Microbiol. Methods 61: 281-284.
224. Morishita N, Sei Y, Sugita T. 2006. Molecular analysis of Malassezia microflora from patients with pityriasis versicolor. Mycopathologia 161: 61-65.
225. Morris DO. 2005. Malassezia pachydermatis carriage in dog owners. Emerg. Infect. Dis. 11:83-88.
226. Morrison VA, Weisdorf DJ. 2000. The spectrum of Malassezia infections in the bone marrow transplant population. Bone Marrow Transplant. 26:645-648.
227. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. 1998. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br. J. Dermatol. 139:33-39.
228. Nakabayashi A, Sei Y, Guillot J. 2000. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med. Mycol. 38:337-341.
229. Naldi L, Rebora A. 2009. Clinical practice. Seborrheic dermatitis. N. Engl. J. Med. 360:387-396.
230. Narang T, Dogra S, Kaur I, Kanwar AJ. 2007. Malassezia and psoriasis: Koebner's phenomenon or direct causation? J. Eur. Acad. Dermatol. Venereol. 21:1111-1112.
231. Nasir A, El Bahesh E, Whitten C, Lawson A, Udall JN Jr. 2010. Pityrosporum folliculitis in a Crohn's disease patient receiving infliximab. Inflamm. Bowel Dis. 16:7-8.
232. Nazzaro-Porro M, Passi S. 1978. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J. Invest. Dermatol. 71:205-208.
233. Nazzaro-Porro M, Passi S, Caprilli F, Mercantini R. 1977. Induction of hyphae in cultures of Pityrosporum by cholesterol and cholesterol esters. J. Invest. Dermatol. 69:355-360.
234. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-691.
235. Nguyen ST, Lund CH, Durand DJ. 2001. Thrombolytic therapy foradhesion of percutaneous central venous catheters to vein intima associated with Malassezia furfur infection. J. Perinatol. 21:331-333.
236. Oberle AD, Fowler M, Grafton WD. 1981. Pityrosporum isolate from the upper respiratory tract. Am. J. Clin. Pathol. 76:112-116.
237. Oh BH, Lee YW, Choe YB, Ahn KJ. 2010. Epidemiologic study of Malassezia yeasts in seborrheic dermatitis patients by the analysis of 26S rDNA PCR-RFLP. Ann. Dermatol. 22:149-155.
238. Oh BH, Song YC, Lee YW, Choe YB, Ahn KJ. 2009. Comparison of nested PCR and RFLP for identification and classification of Malassezia yeasts from healthy human skin. Ann. Dermatol. 21:352-357.
239. Onishi Y, et al. 1999. Two-dimensional electrophoresis of Malassezia allergens for atopic dermatitis and isolation of Mal f 4 homologs with mitochondrial malate dehydrogenase. Eur. J. Biochem. 261:148-154.
240. Panja G. 1927. The Malassezia of the skin, their cultivation, morphology and species. Abstr. Trans. 7th Congr. Far Eastern Assoc. Trop. Med. 2:442-455.
241. Panteleyev AA, Bickers DR. 2006. Dioxin-induced chloracne- reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp. Dermatol. 15:705-730.
242. Papavassilis C, Mach KK, Mayser PA. 1999. Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection. Crit. Care Med. 27:1781-1786.
243. Paulino LC, Tseng CH, Blaser MJ. 2008. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 8:460-471.
244. Paulino LC, Tseng CH, Strober BE, Blaser MJ. 2006. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 44:2933-2941.
245. Pechere M, et al. 1999. Malassezia spp carriage in patients with seborrheic dermatitis. J. Dermatol. 26:558-561.
246. Pierard J, Dockx P. 1972. The ultrastructure of tinea versicolor and Malassezia furfur. Int. J. Dermatol. 11:116-124.
247. Pitkaranta M, et al. 2008. Analysis of fungal flora in indoor dust by ribosomal DNA sequence analysis, quantitative PCR, and culture. Appl. Environ. Microbiol. 74:233-244.
248. Pohjanvirta R, et al. 2002. Comparison of acute toxicities of indolo[3,2- b]carbazole (ICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive rats. Food Chem. Toxicol. 40:1023-1032.
249. Pope M, et al. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78: 389-398.
250. Potter BS, Burgoon CF Jr, Johnson WC. 1973. Pityrosporum folliculitis. Report of seven cases and review of the Pityrosporum organism relative to cutaneous disease. Arch. Dermatol. 107:388-391.
251. Powell DA, Aungst J, Snedden S, Hansen N, Brady M. 1984. Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions. J. Pediatr. 105:987-990.
252. Prober CG, Ein SH. 1984. Tinea versicolor, or how far can furfur go? Pediatr. Infect. Dis. J. 3:592.
253. Prochazkova J, Kozubik A, Machala M, Vondracek J. 2011. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells. Toxicology 279:146-154.
254. Prohic A. 2010. Distribution of Malassezia species in seborrhoeic dermatitis: correlation with patients' cellular immune status. Mycoses 53:344-349.
255. Prohic A, Ozegovic L. 2007. Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor. Mycoses 50: 58-63.
256. Pryce TM, Palladino S, Kay ID, Coombs GW. 2003. Rapid identification of fungi by sequencing the ITS1 and ITS2 regions using an automated capillary electrophoresis system. Med. Mycol. 41:369-381.
257. Pryce TM, et al. 2006. Rapid identification of fungal pathogens in BacT/ ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn. Microbiol. Infect. Dis. 54:289-297.
258. Puig L, Fernandez-Figueras MT, Ferrandiz C, Ribera M, de Moragas JM. 1995. Epidermal expression of 65 and 72 kd heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis. J. Am. Acad. Dermatol. 33:985-989.
259. Rasi A, et al. 2010. Malassezia yeast species isolated from Iranian patients with pityriasis versicolor in a prospective study. Mycoses 53:350-355.
260. Ray S, Swanson HI. 2009. Activation of the aryl hydrocarbon receptor byTCDDinhibits senescence: a tumor promoting event? Biochem. Pharmacol. 77:681-688.
261. Redline RW, Dahms BB. 1981. Malassezia pulmonary vasculitis in an infant on long-term intralipid therapy. N. Engl. J. Med. 305:1395-1398.
262. Redline RW, Redline SS, Boxerbaum B, Dahms BB. 1985. Systemic Malassezia furfur infections in patients receiving intralipid therapy. Hum. Pathol. 16:815-822.
263. Rhie S, Turcios R, Buckley H, Suh B. 2000. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J. Heart Lung Transplant. 19:215-219.
264. Ribbing C, et al. 2011. Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired dectin-1 expression. Allergy 66:110-119.
265. Richet HM, McNeil MM, Edwards MC, Jarvis WR. 1989. Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensivecare unit. J. Clin. Microbiol. 27:1197-1200.
266. Rivolta S. 1873. Parasiti vegetali, 1st ed. Giulio Speirani, Torino, Italy.
267. Robin C. 1853. Histoire naturelle des végétaux parasites qui croissent sur l'homme et les animaux vivants. Baillière, Paris, France.
268. Roe E, et al. 2006. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J. Am. Acad. Dermatol. 55:429-437.
269. Romano C, Maritati E, Ghilardi A, Miracco C, Mancianti F. 2005. A case of pityriasis versicolor atrophicans. Mycoses 48:439-441.
270. Rosales CM, Jackson MA, Zwick D. 2004. Malassezia furfur meningitis associated with total parenteral nutrition subdural effusion. Pediatr. Dev. Pathol. 7:86-90.
271. Rosenberg EW, Belew PW. 1982. Improvement of psoriasis of the scalp with ketoconazole. Arch. Dermatol. 118:370-371.
272. Rothwell TL, Howlett CR, Middleton DJ, Griffiths DA, Duff BC. 1987. Skin neoplasms of dogs in Sydney. Aust. Vet. J. 64:161-164.
273. Saaf AM, et al. 2008. Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One 3:e4017.
274. Sabouraud R. 1904. Maladies du cuir chevelu. II. Les maladies desquamatives. Masson & Cie, Paris, France.
275. Salah SB, et al. 2005. Identification of Malassezia species from Tunisian patients with pityriasis versicolor and normal subjects. Mycoses 48: 242-245.
276. Sanchez JL, Torres VM. 1984. Double-blind efficacy study of selenium sulfide in tinea versicolor. J. Am. Acad. Dermatol. 11:235-238.
277. Sandström Falk MH, et al. 2005. The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm. Venereol. 85:17-23.
278. Schleman KA, Tullis G, Blum R. 2000. Intracardiac mass complicating Malassezia furfur fungemia. Chest 118:1828-1829.
279. Schmid-Grendelmeier P, et al. 2005. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J. Allergy Clin. Immunol. 115:1068-1075.
280. Schoepfer C, et al. 1995. Malassezia furfur septicemia after bone marrow graft. Arch. Pediatr. 2:245-248.
281. Schrenk D, Riebniger D, Till M, Vetter S, Fiedler HP. 1997. Tryptanthrins: a novel class of agonists of the aryl hydrocarbon receptor. Biochem. Pharmacol. 54:165-171.
282. Selander C, Engblom C, Nilsson G, Scheynius A, Andersson CL. 2009. TLR2/MyD88-dependent and-independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J. Immunol. 182:4208-4216.
283. Shek YH, Tucker MC, Viciana AL, Manz HJ, Connor DH. 1989. Malassezia furfur-disseminated infection in premature infants. Am. J. Clin. Pathol. 92:595-603.
284. Shi VS, Lio PA. 2011. Diagnosis of pityriasis versicolor in paediatrics: the evoked scale sign. Arch. Dis. Child. 96:392-393.
285. Shibata N, et al. 2006. Isolation, characterization and molecular cloning of a lipolytic enzyme secreted from Malassezia pachydermatis. FEMS Microbiol. Lett. 256:137-144.
286. Shokohi T, Afshar P, Barzgar A. 2009. Distribution of Malassezia species in patients with pityriasis versicolor in Northern Iran. Indian J. Med. Microbiol. 27:321-324.
287. Shparago NI, Bruno PP, Bennett J. 1995. Systemic Malassezia furfur infection in an adult receiving total parenteral nutrition. J. Am. Osteopath. Assoc. 95:375-377.
288. Shuster S. 1984. The aetiology of dandruff and the mode of action of therapeutic agents. Br. J. Dermatol. 111:235-242.
289. Silva V, Moreno GA, Zaror L, de-Oliveira E, Fischman O. 1997. Isolation of Malassezia furfur from patients with onychomycosis. J. Med. Vet. Mycol. 35:73-74.
290. Simmons RB, Guého E. 1990. A new species of Malassezia. Mycol. Res. 94:1146-1149.
291. Sizun J, et al. 1994. Malassezia furfur-related colonization and infection of central venous catheters. A prospective study in a pediatric intensive care unit. Intensive Care Med. 20:496-499.
292. Slooff WC. 1970. Genus 6 Pityrosporum Sabouraud, p 1167-1186. In Lodder J (ed), The yeasts, a taxonomic study, 2nd ed. North-Holland, Amsterdam, Netherlands.
293. Sternberg TH, Keddie MD. 1961. Immunofluorescence studies in tinea versicolor. Arch. Dermatol. 84:999-1003.
294. Sugita T, et al. 2003. Sequence diversity of the intergenic spacer region of the rRNA gene of Malassezia globosa colonizing the skin of patients with atopic dermatitis and healthy individuals. J. Clin. Microbiol. 41: 3022-3027.
295. Sugita T, et al. 2001. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J. Clin. Microbiol. 39:3486-3490.
296. Sugita T, Tajima M, Amaya M, Tsuboi R, Nishikawa A. 2004. Genotype analysis of Malassezia restricta as the major cutaneous flora in patients with atopic dermatitis and healthy subjects. Microbiol. Immunol. 48:755-759.
297. Sugita T, et al. 2004. A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol. Immunol. 48:579-583.
298. Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. 2006. Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using real-time PCR. Microbiol. Immunol. 50:549-552.
299. Sugita T, Takashima M, Kodama M, Tsuboi R, Nishikawa A. 2003. Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J. Clin. Microbiol. 41:4695-4699.
300. Sugita T, et al. 2002. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J. Clin. Microbiol. 40:1363-1367.
301. Sutter CH, et al. 2009. EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 106:4266-4271.
302. Suwattee P, Cham PM, Solomon RK, Kaye VN. 2009. Tinea versicolor with interface dermatitis. J. Cutan. Pathol. 36:285-286.
303. Suzuki T, Hori N, Miyake T, Hori Y, Mochizuki K. 2007. Keratitis caused by a rare fungus, Malassezia restricta. Jpn. J. Ophthalmol. 51: 292-294.
304. Suzuki T, Ohno N, Ohshima Y, Yadomae T. 2000. Modulation of calcium-induced clot formation of human plasma by Malassezia furfur. Zentralbl. Bakteriol. 289:849-856.
305. Suzuki T, Ohno N, Ohshima Y, Yadomae T. 1998. Soluble mannan and beta-glucan inhibit the uptake of Malassezia furfur by human monocytic cell line, THP-1. FEMS Immunol. Med. Microbiol. 21:223-230.
306. Suzuki T, Tsuzuki A, Ohno N, Ohshima Y, Yadomae T. 2000. Enhancement of IL-8 production from human monocytic and granulocytic cell lines, THP-1 and HL-60, stimulated with Malassezia furfur. FEMS Immunol. Med. Microbiol. 28:157-162.
307. Tajima M, Sugita T, Nishikawa A, Tsuboi R. 2008. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J. Invest. Dermatol. 128:345-351.
308. Takahata Y, Sugita T, Hiruma M, Muto M. 2007. Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay. Br. J. Dermatol. 157:670-673.
309. Takei Y, et al. 2003. Tryptanthrin inhibits interferon-gamma production by Peyer's patch lymphocytes derived from mice that had been orally administered staphylococcal enterotoxin. Biol. Pharm. Bull. 26:365-367.
310. Tanaka M, Imamura S. 1979. Immunological studies on Pityrosporum genus and Malassezia furfur. J. Invest. Dermatol. 73:321-324.
311. Tarazooie B, et al. 2004. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tehran, Iran. BMC Dermatol. 4:5.
312. Tateno H, et al. 2010. Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain. J. Biol. Chem. 285:6390-6400.
313. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. 1994. Trends and sources of nosocomial fungaemia. Mycoses 37: 187-190.
314. Terragni L, Lasagni A, Oriani A, Gelmetti C. 1991. Pityriasis versicolor in the pediatric age. Pediatr. Dermatol. 8:9-12.
315. Theelen B, Silvestri M, Guého E, van Belkum A, Boekhout T. 2001. Identification and typing of Malassezia yeasts using amplified fragment length polymorphism (AFLP), random amplified polymorphic DNA (RAPD) and denaturing gradient gel electrophoresis (DGGE). FEMS Yeast Res. 1:79-86.
316. Thomas DS, Ingham E, Bojar RA, Holland KT. 2008. In vitro modulation of human keratinocyte pro-and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol. Med. Microbiol. 54:203-214.
317. Tschachler E, Bergstresser PR, Stingl G. 1996. HIV-related skin diseases. Lancet 348:659-663.
318. Unna PG. 1887. Seborrheic eczema. J. Cutan. Dis. 5:449-453.
319. van Belkum A, Boekhout T, Bosboom R. 1994. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J. Clin. Microbiol. 32:2528-2532.
320. Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. 2004. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J. Clin. Microbiol. 42:3589-3593.
321. Vilhelmsson M, et al. 2008. Mutational analysis of amino acid residues involved in IgE-binding to the Malassezia sympodialis allergen Mala s 11. Mol. Immunol. 46:294-303.
322. Vilhelmsson M, et al. 2007. Crystal structure of the major Malassezia sympodialis allergen Mala s 1 reveals a beta-propeller fold: a novel fold among allergens. J. Mol. Biol. 369:1079-1086.
323. Vlachos C, et al. 2009. Phospholipase production by Malassezia species in response to beta-endorphin stimulation: a candidate virulence factor? Mycoses 52:105.
324. Vlachos C, et al. 2011. Malassezia produced indoles induce aryl hydrocarbon receptor activation and inhibit Toll-like receptor maturation in monocyte derived dendritic cells. J. Invest. Dermatol. 131:S87.
325. von Bomhard W, et al. 2007. Cutaneous neoplasms in pet rabbits: a retrospective study. Vet. Pathol. 44:579-588.
326. Wahab MA, et al. 2010. Single dose (400 mg) versus 7 day (200 mg) daily dose itraconazole in the treatment of tinea versicolor: a randomized clinical trial. Mymensingh Med. J. 19:72-76.
327. Wallace M, Bagnall H, Glen D, Averill S. 1979. Isolation of lipophilic yeast in "sterile" peritonitis. Lancet ii:956.
328. Wanke I, et al. 2011. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Invest. Dermatol. 131:382-390.
329. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A. 2001. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J. Invest. Dermatol. 116:769-773.
330. Wei YD, Helleberg H, Rannug U, Rannug A. 1998. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole. Chem. Biol. Interact. 110:39-55.
331. Weichel M, Flückiger S, Crameri R. 2002. Molecular characterization of mould allergens involved in respiratory complications. Recent Res. Dev. Respir. Crit. Care Med. 2:29-45.
332. Weidman FD. 1925. Exfoliative dermatitis in the Indian rhinoceros (Rhinoceros unicornis), with description of a new species: Pityrosporum pachydermatis, p 36-43. In Fox H (ed), Report of the Laboratory and Museum of Comparative Pathology of the Zoological Society of Philadelphia. Laboratory and Museum of Comparative Pathology of the Zoological Society of Philadelphia, Philadelphia, PA.
333. Weiss SJ, Schoch PE, Cunha BA. 1991. Malassezia furfur fungemia associated with central venous catheter lipid emulsion infusion. Heart Lung 20:87-90.
334. Werfel T. 2009. The role of leukocytes, keratinocytes, and allergenspecific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 129:1878-1891.
335. Wikler JR, Nieboer C, Willemze R. 1992. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J. Am. Acad. Dermatol. 27:37-39.
336. Wille G, et al. 2001. Malassezin-a novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg. Med. Chem. 9:955-960.
337. Wurtz RM, Knospe WN. 1988. Malassezia furfur fungemia in a patient without the usual risk factors. Ann. Intern. Med. 109:432-433.
338. Xu J, et al. 2007. Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc. Natl. Acad. Sci. U. S. A. 104:18730-18735.
339. Xue C, Hsueh YP, Heitman J. 2008. Magnificent seven: roles of G protein-coupled receptors in extracellular sensing in fungi. FEMS Microbiol. Rev. 32:1010-1032.
340. Yamasaki S, et al. 2009. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl. Acad. Sci. U. S. A. 106: 1897-1902.
341. Yang YS, Shin MK, Haw CR. 2010. Atrophying pityriasis versicolor: is this a new variant of pityriasis versicolor? Ann. Dermatol. 22:456-459.
342. Yarrow D, Ahearn D. 1984. Genus 7 Malassezia Baillon, p 882-885. In Kreger-van Rij NJW (ed), The yeasts, a taxonomic study, 3rd ed. Elsevier Science, Amsterdam, Netherlands.
343. Yates VM, Kerr RE, Frier K, Cobb SJ, MacKie RM. 1983. Early diagnosis of infantile seborrhoeic dermatitis and atopic dermatitis- total and specific IgE levels. Br. J. Dermatol. 108:639-645.
344. Yim SM, et al. 2010. Molecular analysis of Malassezia microflora on the skin of the patients with atopic dermatitis. Ann. Dermatol. 22:41-47.
345. Youn SW, Na JI, Choi SY, Huh CH, Park KC. 2005. Regional and seasonal variations in facial sebum secretions: a proposal for the definition of combination skin type. Skin Res. Technol. 11:189-195.
346. Yu ST, Chen TM, Tseng SY, Chen YH. 2007. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem. Biophys. Res. Commun. 358:79-84.
347. Zargari A, Midgley G, Bäck O, Johansson SG, Scheynius A. 2003. IgE-reactivity to seven Malassezia species. Allergy 58:306-311.
348. Zargari A, et al. 2007. Mala s 12 is a major allergen in patients with atopic eczema and has sequence similarities to theGMCoxidoreductase family. Allergy 62:695-703.
349. Zawar V, Chuh A. 2009. Case report on Malassezia infection of palms and fingernails-speculations on cause for therapeutic failure in pityriasis versicolor. J. Eur. Acad. Dermatol. Venereol. 23:171-172.
350. Zhang H, et al. 2010. Genetic polymorphism of Malassezia furfur isolates from Han and Tibetan ethnic groups in China usingDNAfingerprinting. Med. Mycol. 48:1034-1038.
351. Zhao Y, Li L, Wang JJ, Kang KF, Zhang QQ. 2010. Cutaneous malasseziasis: four case reports of atypical dermatitis and onychomycosis caused by Malassezia. Int. J. Dermatol. 49:141-145.
352. Zitvogel L, Tesniere A, Kroemer G. 2006. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6:715-727.
353. Zomorodian K, et al. 2008. Distribution of Malassezia species in patients with psoriasis and healthy individuals in Tehran, Iran. J. Cutan. Pathol. 35:1027-1031.
354. Zouboulis CC, et al. 2008. Frontiers in sebaceous gland biology and pathology. Exp. Dermatol. 17:542-551.
355. Zuther K, et al. 2008. The tryptophan aminotransferase Tam1 catalyses the single biosynthetic step for tryptophan-dependent pigment synthesis in Ustilago maydis. Mol. Microbiol. 68:152-172.